Literature DB >> 20407782

Inflammatory aneurysm of the abdominal aorta in a patient treated with ropinirole.

Dimitrios Parissis, Athanasia Papachristodoulou, Athanasios Dimitriadis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20407782     DOI： 10.1007/s00415-010-5568-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Fibrosis associated with dopamine agonist therapy in Parkinson's disease.

Authors:  Thomas Müller; Jürgen Fritze
Journal:  Clin Neuropharmacol       Date:  2003 May-Jun       Impact factor: 1.592

2.  Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease.

Authors:  Sunku H Guptha; Anthony D Promnitz
Journal:  Eur J Intern Med       Date:  2005-04       Impact factor: 4.487

Review 3.  Retroperitoneal fibrosis.

Authors:  Augusto Vaglio; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

4.  Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.

Authors:  Frank Andersohn; Edeltraut Garbe
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

Review 5.  Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review.

Authors:  Malcolm Steiger; W Jost; F Grandas; G Van Camp
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

6.  Diagnosis and management of pergolide-induced fibrosis.

Authors:  Pinky Agarwal; Stanley Fahn; Steven J Frucht
Journal:  Mov Disord       Date:  2004-06       Impact factor: 10.338

7.  Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment.

Authors:  Xi-Ping Huang; Vincent Setola; Prem N Yadav; John A Allen; Sarah C Rogan; Bonnie J Hanson; Chetana Revankar; Matt Robers; Chris Doucette; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2009-07-01       Impact factor: 4.436

Review 8.  Chronic periaortitis: a fibro-inflammatory disorder.

Authors:  Alessandra Palmisano; Augusto Vaglio
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-06       Impact factor: 4.098

Review 9.  Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy.

Authors:  Hiroki Aoki; Koichi Yoshimura; Masunori Matsuzaki
Journal:  J Mol Med (Berl)       Date:  2007-05-24       Impact factor: 4.599
  9 in total
  1 in total

Review 1.  Serotonin receptors and heart valve disease--it was meant 2B.

Authors:  Joshua D Hutcheson; Vincent Setola; Bryan L Roth; W David Merryman
Journal:  Pharmacol Ther       Date:  2011-04-02       Impact factor: 12.310
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.